Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(A Methapred)
29,993 results
  • Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2. [Case Reports]
    Cureus. 2022 Dec; 14(12):e33076.Alves J, Salgueiro A, … Martins P
  • We present a case of severe pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a 63-year-old woman needing venous oxygenation by an extracorporeal membrane. Given the difficult clinical resolution with persistent inflammatory parameters, treatment with corticosteroids (methylprednisolone) was prescribed. The clinical evolution observed, namely the improvement of r…
  • Steroid administration for post-COVID-19 Parkinsonism: A case report. [Case Reports]
    Neurol Clin Neurosci. 2023 Jan; 11(1):49-51.Mitarnun W, Apiwattanakul M, … Pangwong W
  • A 45-year-old man developed parkinsonism 3 weeks after being diagnosed with mild COVID-19. Levodopa and benserazide failed to improve his symptoms, necessitating ropinirole, and steroid treatment, which included a 5-day course of methylprednisolone followed by a 3-month oral prednisolone taper. One month after initiating steroid treatment, his symptoms improved significantly.
  • Anti-N-methyl-D-aspartate Receptor Autoimmune Encephalitis: A Case Report. [Case Reports]
    JNMA J Nepal Med Assoc. 2022 Nov 02; 60(255):962-964.Yadav B, Chaurasia D, … Dhungana K
  • Anti-N-methyl-D-aspartate receptor encephalitis is a form of autoimmune encephalitis with acute or subacute neuropsychiatric symptoms. Despite this fact, due to a couple of factors, this condition remains insufficiently acknowledged and is an under-recognised clinical scenario. We describe a case of a patient presenting with fever, headache and altered sensorium along with a history of disorienta…
  • A case of antisynthetase syndrome presenting solely with life-threatening interstitial lung disease. [Case Reports]
    Clin Med (Lond). 2023 Jan; 23(1):85-87.Tranah E, MacBrayne A, … Mukerjee D
  • A previously fit and well 38-year-old man presented during the COVID-19 pandemic with dyspnoea, cough and palpitations. C-reactive protein was elevated and chest X-ray demonstrated bilateral lower zone consolidation. SARS CoV-2 swab was negative. He was diagnosed with community-acquired pneumonia and treated with oral antibiotics. He developed severe type 1 respiratory failure and was admitted to…
  • Rheumatoid Meningitis in a patient with Overlap Syndrome: the usefulness of ACPA determination in CSF. [Journal Article]
    Mod Rheumatol Case Rep. 2023 Jan 25 [Online ahead of print]Barreto PL, Ariño GR, … Buisán Catevilla FJ
  • Rheumatoid Meningitis (RM) is a rare complication of Rheumatoid Arthritis (RA) that can manifest as stroke-like episodes. We present the case of a 63-year-old woman with a past history of Overlap Syndrome (OS) and clinical manifestations suggestive of Amyopathic Dermatomyositis, Rheumatoid Arthritis, and Systemic Lupus Erythematosus. She presented to the emergency department with sudden onset rig…
  • Clinical characteristic of myelin oligodendrocyte glycoprotein antibody associated cortical encephalitis in adults and outcomes following glucocorticoid therapy. [Journal Article]
    Front Aging Neurosci. 2022; 14:1076361.Wu Y, Zhou H, … Lu J
  • CONCLUSIONS: The clinical manifestations of adult MOG antibody-associated cortical encephalitis were significantly different from those of the typical MOG antibody-associated disease (MOGAD). Patients in the acute phase of the disease were prone to show signs similar to central nervous system infection, requiring clinicians to have the ability to recognize the disease to avoid misdiagnosis. In addition, seizures were common in MOG antibody-related encephalitis, and the type of seizures was age-related. Brain MRI results showed that the distribution of cerebral cortex lesions was closely related to the classification of cortical encephalitis. Based on the patient's response to the treatment, glucocorticoid therapy was effective against MOG antibody-associated cortical encephalitis, which is consistent with the treatment response and clinical prognosis of MOGAD. Therefore, our opinion was that MOG antibody might be the "responsible antibody" in MOG antibody-associated cortical encephalitis, although further studies are needed to confirm this hypothesis.
New Search Next